Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Dec;14(6):609-15.
doi: 10.1007/s10522-013-9451-6. Epub 2013 Aug 9.

Mechanistic links between aging and lung fibrosis

Affiliations
Review

Mechanistic links between aging and lung fibrosis

Victor J Thannickal. Biogerontology. 2013 Dec.

Abstract

Our understanding of the biology of aging has advanced significantly in recent years. This has resulted in the recent formulation of the "hallmarks of aging" that include genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion, and altered intercellular communication. Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal lung disease that results from the accumulation of scar tissue in the lungs of affected individuals. IPF is a disease of aging that most commonly affects human subjects older than 60 years of age. While progress has been made in elucidating key pathological processes in IPF, the relationship of these processes to those that occur during aging are not well defined. In this review, we explore existing and emerging paradigms in the pathogenesis of IPF in light of the recently defined hallmarks of aging.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Alder JK, Chen JJ, Lancaster L, Danoff S, Su SC, Cogan JD, Vulto I, Xie M, Qi X, Tuder RM, Phillips JA, 3rd, Lansdorp PM, Loyd JE, Armanios MY. Short telomeres are a risk factor for idiopathic pulmonary fibrosis. Proc Natl Acad Sci U S A. 2008;105 (35):13051–13056. doi: 10.1073/pnas.0804280105. 0804280105 [pii] - DOI - PMC - PubMed
    1. Araya J, Kojima J, Takasaka N, Ito S, Fujii S, Hara H, Yanagisawa H, Kobayashi K, Tsurushige C, Kawaishi M, Kamiya N, Hirano J, Odaka M, Morikawa T, Nishimura SL, Kawabata Y, Hano H, Nakayama K, Kuwano K. Insufficient autophagy in idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 2013;304 (1):L56–69. doi: 10.1152/ajplung.00213.2012. - DOI - PubMed
    1. Armanios M. Telomerase and idiopathic pulmonary fibrosis. Mutat Res. 2012;730 (1–2):52–58. doi: 10.1016/j.mrfmmm.2011.10.013. - DOI - PMC - PubMed
    1. Armanios M. Telomeres and age-related disease: how telomere biology informs clinical paradigms. J Clin Invest. 2013;123 (3):996–1002. doi: 10.1172/JCI66370. - DOI - PMC - PubMed
    1. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, Markin C, Lawson WE, Xie M, Vulto I, Phillips JA, 3rd, Lansdorp PM, Greider CW, Loyd JE. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007;356 (13):1317–1326. doi: 10.1056/NEJMoa066157. 356/13/1317 [pii] - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources

  NODES
twitter 2